Disease ID | Disease name | Source of annotation with IKBKG | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
300301 | ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA | ClinVar, OMIM | link to OMIM | 1 | IKBKG |
308300 | INCONTINENTIA PIGMENTI | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
300636 | IMMUNODEFICIENCY 33 | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
300291 | ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
PS610799 | INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED | ClinVar, OMIM, HUMSAVAR | link to OMIM | 3 | IKBKG, TIRAP, IRAK4 |
300584 | IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA | OMIM, HUMSAVAR | link to OMIM | 1 | IKBKG |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Shigellosis | hsa05131 | 6.74 |
Pancreatic cancer | hsa05212 | 6.56 |
MAPK signaling pathway | hsa04010 | 4.63 |
Prostate cancer | hsa05215 | 6.11 |
Primary immunodeficiency | hsa05340 | 7.52 |
Osteoclast differentiation | hsa04380 | 5.64 |
NF-kappa B signaling pathway | hsa04064 | 6.21 |
Chemokine signaling pathway | hsa04062 | 5.19 |
Adipocytokine signaling pathway | hsa04920 | 6.6 |
Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
Herpes simplex infection | hsa05168 | 5.08 |
Epstein-Barr virus infection | hsa05169 | 4.97 |
Toxoplasmosis | hsa05145 | 5.71 |
Apoptosis | hsa04210 | 6.23 |
HTLV-I infection | hsa05166 | 4.59 |
Hepatitis C | hsa05160 | 5.68 |
Hepatitis B | hsa05161 | 5.52 |
Epithelial cell signaling in Helicobacter pylori infection | hsa05120 | 6.58 |
Toll-like receptor signaling pathway | hsa04620 | 6.0 |
NOD-like receptor signaling pathway | hsa04621 | 6.88 |
Viral carcinogenesis | hsa05203 | 5.08 |
Pathways in cancer | hsa05200 | 3.98 |
T cell receptor signaling pathway | hsa04660 | 6.01 |
B cell receptor signaling pathway | hsa04662 | 6.52 |
Ras signaling pathway | hsa04014 | 4.9 |
RIG-I-like receptor signaling pathway | hsa04622 | 6.62 |
Acute myeloid leukemia | hsa05221 | 6.74 |
Chronic myeloid leukemia | hsa05220 | 6.48 |
TNF signaling pathway | hsa04668 | 5.96 |
Cytosolic DNA-sensing pathway | hsa04623 | 6.79 |
PI3K-Akt signaling pathway | hsa04151 | 4.21 |
Small cell lung cancer | hsa05222 | 6.17 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
Signaling by Interleukins | R-HSA-449147 | 4.71 |
IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.46 |
Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
Immune System | R-HSA-168256 | 2.37 |
Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.34 |
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | R-HSA-168928 | 6.7 |
FCERI mediated NF-kB activation | R-HSA-2871837 | 5.11 |
Innate Immune System | R-HSA-168249 | 3.17 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
Disease | R-HSA-1643685 | 3.33 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.18 |
Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
IkBA variant leads to EDA-ID | R-HSA-5603029 | 10.18 |
Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.28 |
Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.94 |
TCR signaling | R-HSA-202403 | 6.64 |
Interleukin-1 signaling | R-HSA-446652 | 7.52 |
TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.4 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 9.4 |
activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.59 |
Downstream TCR signaling | R-HSA-202424 | 7.01 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
NOD1/2 Signaling Pathway | R-HSA-168638 | 7.85 |
MAP kinase activation in TLR cascade | R-HSA-450294 | 7.28 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | R-HSA-445989 | 8.08 |
RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.59 |
Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
Diseases of Immune System | R-HSA-5260271 | 8.34 |
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 9.98 |
IRAK1 recruits IKK complex | R-HSA-937039 | 9.18 |
Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
IKBKB deficiency causes SCID | R-HSA-5602636 | 11.4 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.31 |
MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
Activated TLR4 signalling | R-HSA-166054 | 6.27 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.66 |
Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
GO term | GO ID | GO IC |
---|---|---|
linear polyubiquitin binding | GO:1990450 | 9.74 |
ubiquitin-like protein ligase binding | GO:0044389 | 4.15 |
enzyme binding | GO:0019899 | 2.27 |
binding | GO:0005488 | 0.18 |
signal transducer activity | GO:0004871 | 2.28 |
polyubiquitin binding | GO:0031593 | 5.98 |
cation binding | GO:0043169 | 1.4 |
ion binding | GO:0043167 | 1.36 |
transferase activity | GO:0016740 | 1.95 |
K63-linked polyubiquitin binding | GO:0070530 | 6.79 |
metal ion binding | GO:0046872 | 1.41 |
identical protein binding | GO:0042802 | 2.63 |
protein homodimerization activity | GO:0042803 | 3.16 |
kinase activity | GO:0016301 | 2.93 |
catalytic activity | GO:0003824 | 1.05 |
protein domain specific binding | GO:0019904 | 3.32 |
protein dimerization activity | GO:0046983 | 2.72 |
ubiquitin protein ligase binding | GO:0031625 | 4.17 |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
ubiquitin-like protein binding | GO:0032182 | 4.93 |
ubiquitin binding | GO:0043130 | 5.09 |
protein binding | GO:0005515 | 0.46 |
peroxisome proliferator activated receptor binding | GO:0042975 | 7.03 |
receptor binding | GO:0005102 | 2.43 |
protein heterodimerization activity | GO:0046982 | 3.64 |